ANN ARBOR, Mich., Feb. 09, 2022 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

ANN ARBOR, Mich., Dec. 22, 2020 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, today ...

) has been revised to $3.06 / share. This is a decrease of 62.50% from the prior estimate of $8.16 dated June 1, 2023. The price target is an average of many targets provided by analysts. The latest ...

In the immediate aftermath of the COVID-19 pandemic, virtually every economic sector suffered a severe loss of commercial activity as millions of Americans began sheltering in place. However, with the ...

Orion Properties Inc. Annual cash flow by MarketWatch. View ONL net cash flow, operating cash flow, operating expenses and cash dividends.

ONL is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of ONL shares has decreased $0.01 since the market last closed. This is a 0.36% ...